All In Biotech

Drug Trial Radar · NCT06809595

A Phase 3 Trial of MM120 for Generalized Anxiety Disorder (Panorama)

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, 12-Week Study (Part A) With a 40 Week Open-label Extension (Part B) Evaluating the Efficacy and Safety of Oral MM120 Compared to Placebo in the Treatment of Adults With Generalized Anxiety Disorder - Panorama

Last checked: Nov 19, 2026Latest source record: Sep 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 245 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

245

Actual

Start

Jan 29, 2025

Primary completion

Aug 13, 2026

Study completion May 2027

Sponsor

Lead sponsor
Definium Therapeutics US, Inc.Industry
Sponsor type
Industry
First posted
Feb 5, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 74 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A Phase 3, Double-blind, Placebo-controlled Study (Part A) with an Open-label Extension (Part B) Evaluating DT120 Compared to Placebo in Generalized Anxiety Disorder - Panorama

Conditions

  • Generalized Anxiety Disorder

Interventions

  • PlaceboOther

    A substance that is designed to have no therapeutic value

  • DT120Drug

    A psychoactive substance that mediates effects mainly through an agonist activity in the serotonin 2A receptor (5-HT2A)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from Baseline in Hamilton Anxiety Rating Scale (HAM-A) total score at Week 12Time frame: Baseline to Week 12

Locations

36 sites in 6 countries. Site status is shown where the registry gives one.

  • Preferred Research Partners, Inc.

    Little Rock, Arkansas

  • Psychedelic Science Institute

    Los Angeles, California

  • West Los Angeles VA Medical Center

    Los Angeles, California

  • Bradenton Research Center, Inc.

    Bradenton, Florida

  • Clinical Neuroscience Solutions, Inc

    Orlando, Florida

  • Atlanta Center for Medical Research

    Atlanta, Georgia

  • Sheppard Pratt Health System

    Towson, Maryland

  • Adams Clinical Boston

    Boston, Massachusetts

  • Princeton Medical Institute

    Princeton, New Jersey

  • University of Cincinnati Psychiatry- Anxiety Disorders Research Program

    Cincinnati, Ohio

  • Neuro-Behavioral Clinical Research, Inc.

    North Canton, Ohio

  • Austin Clinical Trial Partners

    Austin, Texas

  • Core Clinical Research

    Everett, Washington

  • A-shine s.r.o.

    Pilsen, Czechia

  • Institut Neuropsychiatricke Pece (INEP)

    Prague, Czechia

  • Psyon s.r.o.

    Prague, Czechia

  • Cabinet Dr.Desbonnet : Résidence Saint Michel

    Douai, France

  • Hôpital Conception, CIC Centre, bat néphrologie 3eme étage

    Marseille, France

  • CMME

    Paris, France

  • GHU Paris Psychiatrie et Neurosciences

    Paris, France

  • Centre Hospitalier du Rouvray

    Sotteville-lès-Rouen, France

  • Department of Psychiatry and Psychotherapy Campus Charité Mitte Charité Universitätsmedizin Berlin

    Berlin, Germany

  • OVID Clinic Berlin

    Berlin, Germany

  • Central Institute of Mental Health

    Mannheim, Germany

  • Klinik für Psychiatrie und Psychotherapie, Abt: Allgemeine Psychiatrie und Psychotherapie

    Tübingen, Germany

  • Centrum Badan Klinicznych PI-House sp. z o.o.

    Gdansk, Poland

  • Department of Psychiatry, UCK

    Gdansk, Poland

  • Department of Affective and Psychotic Disorders, Central Teaching Hospital, Medical University of Lodz

    Lodz, Poland

  • Neuroclin Glasgow

    Glasgow, United Kingdom

  • Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust, St. Nicholas Hospital

    Gosforth, United Kingdom

  • 4 Medical Clinical Solutions

    London, United Kingdom

  • Clerkenwell Health - Baker Street

    London, United Kingdom

  • Clerkenwell Health

    London, United Kingdom

  • South London and Maudsley NHS Foundation Trust of The Maudsley Hospital

    London, United Kingdom

  • 4 Medical Clinical Solutions

    Manchester, United Kingdom

  • St George's Community Health Centre

    Sheffield, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.